With industry waiting on the FDA to issue regs for CBD products, the agency instead released a statement explaining why it has not yet done so—including fears that the trendy cannabinoid may cause liver damage. But advocates charge that the claim is based on faulty research.
Recent comments
12 weeks 2 days ago
16 weeks 3 days ago
18 weeks 13 hours ago
18 weeks 1 day ago
30 weeks 3 days ago
36 weeks 1 day ago
47 weeks 1 day ago
48 weeks 22 hours ago
49 weeks 4 days ago
50 weeks 1 day ago